학술논문
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
Document Type
Article
Author
Amiot, A.; Gagniere, C.; Serrero, M.; Peyrin-Biroulet, L.; Filippi, J.; Pariente, B.; Roblin, X.; Buisson, A.; Stefanescu, C.; Bouhnik, Y.; Trang-Poisson, C.; Altwegg, R.; Marteau, P.; Bourrier, A.; Allez, M.; Pelletier, A.-L.; Abitbol, V.; Vaysse, T.; Nancey, S.; Laharie, D.; Savoye, G.; Moreau, J.; Vuitton, L.; Viennot, S.; Aubourg, A.; Bouguen, G.; Grimaud, J.-C.; Zallot, C.; Bigard, M.-A.; Hebuterne, X.; Nachury, M.; Desreumaux, P.; del Tedesco, E.; Bommelaer, G.; Boureille, A.; Dray, X.; Carbonnel, F.; Seksik, P.; Beaugerie, L.; Cosnes, J.; Sokol, H.; Landman, C.; Boschetti, G.; Poullenot, F.; Gornet, J.-M.; Baudry, C.; Koch, S.; Picon, L.; Sickersen, G.; Chaussade, S.; Nahon, S.; Winkfield, B.; Brixi-benmansour, H.; Gincul, R.; Barberis, J.-C.; Bonaz, B.; Michiels, C.; Zerbib, F.; de Beauregard, M.B.; Locher, C.; Davin-Couve, S.; Poirette, A.; Guillem, L.; Stetiu-Mocanu, M.; Philippe, B.; Beorchia, S.; Al Qaddi, J.
Source
In: Alimentary Pharmacology and Therapeutics . (Alimentary Pharmacology and Therapeutics, 1 August 2017, 46(3):310-321)
Subject
Language
English
ISSN
13652036
02692813
02692813